Gilead Sciences Inc
Change company Symbol lookup
Select an option...
GILD Gilead Sciences Inc
ZN Zion Oil and Gas Inc
EBTC Enterprise Bancorp Inc
FSLY Fastly Inc
BNR Burning Rock Biotech Ltd
FCNKX Fidelity® Contrafund® Fund Class K
CAT Caterpillar Inc
POAGX PRIMECAP Odyssey Aggressive Growth Fund
VFIFX Vanguard Target Retirement 2050 Fund Investor Shares
CMCSA Comcast Corp
Go

Health Care : Biotechnology | Large Cap Value
Company profile

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes medicines in areas of unmet medical need. The Company's portfolio of products and pipeline of investigational drugs includes treatments for Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS), liver diseases, cancer, inflammatory and respiratory diseases and cardiovascular conditions. Its products for HIV/AIDS patients include Descovy, Odefsey, Genvoya, Stribild, Complera/Eviplera, Truvada, Emtriva, Tybost and Vitekta. Its products for patients with liver diseases include Vemlidy, Epclusa, Harvoni, Sovaldi, Viread and Hepsera. It offers Zydelig to patients with hematology/oncology diseases. Its products for patients with various cardiovascular diseases include Letairis, Ranexa and Lexiscan. Its products for various inflammation/respiratory diseases include Cayston and Tamiflu. It had operations in more than 30 countries, as of December 31, 2016.

Premarket

Last Trade
Delayed
$68.03
-0.15 (-0.22%)
Bid
--
Ask
--
B/A Size
--

Market Hours

Closing Price
$68.18
Day's Change
0.00 (0.00%)
Bid close
--
Ask close
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
140

10-day average volume:
10,460,783
140
  • Prev Close
    68.18
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    10.5M
  • Last (time)
    4:00p ET 08/13/20
  • Last (size)
    56
  • 52-Wk Range
    60.89 - 85.97
    LowHigh
  • (10/03/19 - 03/19/20)
    11.97%
  • 37.3%
  • Market Cap
    85.5B
  • Shares Outstanding
    1.3B
  • -0.24
  • --
  • $2.72/3.95%
  • Ex-dividend Date
    09/14/20
  • Dividend Pay Date
    09/29/20
  • 0.6
  • 79.10
  • (% of float 07/31/20)
    1.71

Latest News

August 13, 2020
11:56 am ET
MarketWatch
6:46 am ET
MarketWatch
August 11, 2020
8:11 am ET
BusinessWire
August 10, 2020
11:00 am ET
BusinessWire
9:00 am ET
PR Newswire
August 07, 2020
9:11 am ET
MarketWatch
8:11 am ET
MarketWatch
8:03 am ET
MarketWatch
8:02 am ET
MarketWatch
August 06, 2020
1:19 pm ET
PR Newswire
8:45 am ET
PR Newswire
August 05, 2020
7:58 am ET
MarketWatch
August 04, 2020
7:27 pm ET
BusinessWire
10:31 am ET
Globe Newswire
July 31, 2020
6:13 am ET
MarketWatch
July 30, 2020
4:02 pm ET
BusinessWire
4:01 pm ET
BusinessWire
July 28, 2020
9:00 am ET
BusinessWire
July 27, 2020
1:31 pm ET
MarketWatch
July 24, 2020
1:25 pm ET
BusinessWire
8:10 am ET
BusinessWire
July 23, 2020
10:08 am ET
PR Newswire
6:30 am ET
PR Newswire
July 21, 2020
9:20 am ET
Globe Newswire
8:43 am ET
MarketWatch
8:34 am ET
MarketWatch
8:34 am ET
MarketWatch
8:30 am ET
PR Newswire
8:30 am ET
BusinessWire
July 20, 2020
1:20 pm ET
PR Newswire
July 16, 2020
4:01 pm ET
BusinessWire
July 15, 2020
9:00 am ET
PR Newswire
July 13, 2020
4:05 pm ET
BusinessWire
8:30 am ET
PR Newswire
July 11, 2020
10:26 am ET
MarketWatch
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.